1. Home
  2. BETR vs MRVI Comparison

BETR vs MRVI Comparison

Compare BETR & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Better Home & Finance Holding Company

BETR

Better Home & Finance Holding Company

HOLD

Current Price

$47.45

Market Cap

538.7M

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.57

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BETR
MRVI
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
538.7M
472.8M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BETR
MRVI
Price
$47.45
$3.57
Analyst Decision
Buy
Buy
Analyst Count
1
4
Target Price
$40.00
$4.13
AVG Volume (30 Days)
569.3K
1.9M
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
N/A
Revenue
N/A
$185,743,000.00
Revenue This Year
$54.06
$12.44
Revenue Next Year
$66.68
$7.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.81
$1.78
52 Week High
$94.06
$4.11

Technical Indicators

Market Signals
Indicator
BETR
MRVI
Relative Strength Index (RSI) 65.83 65.91
Support Level $41.87 $3.25
Resistance Level $51.16 $3.65
Average True Range (ATR) 3.81 0.18
MACD 0.92 0.08
Stochastic Oscillator 96.77 93.73

Price Performance

Historical Comparison
BETR
MRVI

About BETR Better Home & Finance Holding Company

Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: